Literature DB >> 24648581

In Vitro Antifungal Activity of Ankaferd Blood Stopper Against Candida albicans.

Sevgi Ciftci1, Fahriye Keskin1, Sema Keceli Ozcan2, Mehmet Ali Erdem3, Burak Cankaya3, Recep Bingol2, Cetin Kasapoglu3.   

Abstract

BACKGROUND: Candida albicans is a memeber of the oral flora that can lead to various complications in immunosupresive patients after oral surgery processes. Ankaferd Blood Stopper® (ABS) is a medical plant extract that is safe to use in patients with dental surgery bleedings in Turkey.
OBJECTIVE: The study evaluated the antifungal activity of ABS medicinal plant extract against C albicans using the agar diffusion and broth microdilution methods.
METHODS: The plant extract antifungal activity was assessed in vitro either by applying the ABS extract directly and by applying different concentrations of ABS onto Candida culture. For these experiments, an agar diffusion method was used. To determine the minimum inhibitory concentration (MIC), a broth microdilution method was used.
RESULTS: Different volumes of the active substance (10, 20, 30, and 40 μL) were applied onto Candida (0.5 McFarland solution) cultivated plate; Candida growth was inhibited in accordance with the volumes of ABS. However, when various dilutions of ABS (1:2, 1:20, 1:40, and 1:80) were added as drops containing 20 μL, no antifungal effects were found. No MIC values were identified using broth microdilution. When different dilutions of ABS containing 100 μL of 0.5 McFarland solution of C albicans were cultured depending on the time (10, 20, 30, and 40 minutes), the effect of the duration was not significant.
CONCLUSION: The various tests were carried out to investigate antifungal effects of ABS on Candida, but none were found.

Entities:  

Keywords:  Ankaferd Blood Stopper; Candida; antifungal activity; in vitro

Year:  2011        PMID: 24648581      PMCID: PMC3957156          DOI: 10.1016/j.curtheres.2011.04.003

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


  13 in total

1.  Inhibition of Clotrimazole-resistant Candida albicans by plants used in Iranian folkloric medicine.

Authors:  G H Shahidi Bonjar
Journal:  Fitoterapia       Date:  2004-01       Impact factor: 2.882

2.  Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper.

Authors:  H Goker; I C Haznedaroglu; S Ercetin; S Kirazli; U Akman; Y Ozturk; H C Firat
Journal:  J Int Med Res       Date:  2008 Jan-Feb       Impact factor: 1.671

3.  Antifungal activity of Glycyrrhiza glabra extracts and its active constituent glabridin.

Authors:  Atiya Fatima; Vivek K Gupta; Suaib Luqman; Arvind S Negi; J K Kumar; Karuna Shanker; Dharmendra Saikia; Suchita Srivastava; M P Darokar; Suman P S Khanuja
Journal:  Phytother Res       Date:  2009-08       Impact factor: 5.878

4.  Antimicrobial activity of plant extract Ankaferd Blood Stopper.

Authors:  Nuriye Tasdelen Fisgin; Yeliz Tanriverdi Cayci; Ahmet Yilmaz Coban; Duzgun Ozatli; Esra Tanyel; Belma Durupinar; Necla Tulek
Journal:  Fitoterapia       Date:  2008-10-07       Impact factor: 2.882

Review 5.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

6.  PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies.

Authors:  G Morace; L Pagano; M Sanguinetti; B Posteraro; L Mele; F Equitani; G D'Amore; G Leone; G Fadda
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

7.  Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus.

Authors:  Riina Rautemaa; Peter Rusanen; Malcolm Richardson; Jukka H Meurman
Journal:  J Med Microbiol       Date:  2006-10       Impact factor: 2.472

8.  Screening of traditionally used South African plants for antifungal activity against Candida albicans.

Authors:  M L Motsei; K L Lindsey; J van Staden; A K Jäger
Journal:  J Ethnopharmacol       Date:  2003-06       Impact factor: 4.360

9.  In vitro effects of glycyrrhetinic acid on the growth of clinical isolates of Candida albicans.

Authors:  Donatella Pellati; Cristina Fiore; Decio Armanini; Mario Rassu; Giulio Bertoloni
Journal:  Phytother Res       Date:  2009-04       Impact factor: 5.878

10.  Plant extract ankaferd blood stopper effect on bond strength.

Authors:  Goksu Trakyali; M Oguz Oztoprak
Journal:  Angle Orthod       Date:  2010-05       Impact factor: 2.079

View more
  9 in total

1.  Effective Ankaferd Hemostat Treatment For Severe Intractable Chronic Deep Leg Ulcer Associated With Behçet's Disease.

Authors:  Rafiye Çiftçiler; Erdinç Çiftçiler; İbrahim Haznedaroğlu
Journal:  Arch Rheumatol       Date:  2019-04-26       Impact factor: 1.472

2.  Role of Ankaferd on bacterial translocation and inflammatory response in an experimental rat model of intestinal obstruction.

Authors:  Velat Sen; Unal Uluca; Aydın Ece; Ali Güneş; Hikmet Zeytun; Serkan Arslan; Ibrahim Kaplan; Gül Türkçü; Recep Tekin
Journal:  Int J Clin Exp Med       Date:  2014-09-15

3.  Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids.

Authors:  Ahmet Koluman; Nejat Akar; Umit Y Malkan; Ibrahim C Haznedaroglu
Journal:  Biomed Res Int       Date:  2016-01-26       Impact factor: 3.411

Review 4.  Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper.

Authors:  Cem Simsek; Sebnem Selek; Meltem Koca; Ibrahim Celal Haznedaroglu
Journal:  SAGE Open Med       Date:  2017-07-27

5.  Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases.

Authors:  Ahmet Koluman; Nejat Akar; İbrahim C Haznedaroğlu
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

6.  Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines.

Authors:  Seyhan Turk; Umit Yavuz Malkan; Mehdi Ghasemi; Helin Hocaoglu; Duygu Mutlu; Gursel Gunes; Salih Aksu; Ibrahim Celalettin Haznedaroglu
Journal:  SAGE Open Med       Date:  2017-02-10

7.  Effectiveness of Ankaferd BloodStopper in Prophylaxis and Treatment of Oral Mucositis in Childhood Cancers Evaluated with Plasma Citrulline Levels.

Authors:  Türkan Patıroğlu; Nagihan Erdoğ Şahin; Ekrem Ünal; Mustafa Kendirci; Musa Karakükcü; Mehmet Akif Özdemir
Journal:  Turk J Haematol       Date:  2018-02-02       Impact factor: 1.831

Review 8.  Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).

Authors:  Rafiye Ciftciler; Ali Erdinc Ciftciler; Umit Yavuz Malkan; Ibrahim C Haznedaroglu
Journal:  SAGE Open Med       Date:  2020-02-16

9.  The effect of Ankaferd blood stopper on liver damage in experimental obstructive jaundice

Authors:  Koray Koşmaz; Abdullah Durhan; Marlen Süleyman; Yılmaz Ünal; Mustafa Taner Bostancı; Tuğba Yiğit Haskaraca; Can Ersak; Mehmet Şener; İlknur Alkan Kuşabbi; Eylem Pınar Eser; Sema Hücümenoğlu
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.